Share on StockTwits

Lannett Co. (NYSE:LCI) was downgraded by equities research analysts at Jefferson Research from a “hold” rating to a “sell” rating in a research note issued to investors on Friday, AnalystRatings.NET reports.

Shares of Lannett Co. (NYSE:LCI) traded up 0.03% on Friday, hitting $37.69. 94,629 shares of the company’s stock traded hands. Lannett Co. has a 52-week low of $6.58 and a 52-week high of $38.78. The stock has a 50-day moving average of $34.64 and a 200-day moving average of $24.47. The company has a market cap of $1.314 billion and a P/E ratio of 65.87.

Lannett Co. (NYSE:LCI) last released its earnings data on Thursday, February 6th. The company reported $0.46 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.39 by $0.07. The company had revenue of $67.30 million for the quarter, compared to the consensus estimate of $62.21 million. The company’s quarterly revenue was up 84.1% on a year-over-year basis. Analysts expect that Lannett Co. will post $1.85 EPS for the current fiscal year.

Several other analysts have also recently commented on the stock. Analysts at Zacks upgraded shares of Lannett Co. from a “neutral” rating to an “outperform” rating in a research note on Tuesday. They now have a $40.10 price target on the stock. Separately, analysts at TheStreet upgraded shares of Lannett Co. from a “hold” rating to a “buy” rating in a research note on Monday. Finally, analysts at Canaccord Genuity raised their price target on shares of Lannett Co. from $29.00 to $55.00 in a research note on Monday. They now have a “buy” rating on the stock. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and five have given a buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $43.53.

Lannett Company, Inc is engaged in developing, manufacturing, marketing and distributing generic versions of branded pharmaceutical products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.